Arthritis care costs Australia A$24B/year

26 January 2009

Research, supported by USA-headquartered pharmaceutical company Wyeth Pharmaceuticals and undertaken by Leadership Factor, shows that  Australians with arthritis use medicines extensively to manage their  pain.

The survey, conducted in the last quarter of 2007, was to provide  information on how patients managed arthritis pain and the various  medicines they used, and was intended to help guide development of new  policies, as well as support programs by Arthritis NSW.

A key finding of the Medical Management of Arthritis study, which  included a patient survey with 4,911 returns across several states, was  that 70% of people with the disease seek relief through prescription  medicines and, of this number, 87% take between one and three  prescribed medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight